Upfront Payments in Biotech Deals by Therapeutic Category
Executive Summary
This month, we compared upfront payments in biotech deals signed at the R&D or preclinical phase of development by therapeutic category. These deals tend to be weighted more towards equity purchases. Here we've graphed these payments starting in1991 through June 1996.